Attivare Therapeutics is a biotechnology company that develops small-molecule therapies that modulate immune and inflammatory pathways.
Attivare Therapeutics has raised $6.6M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Attivare Therapeutics's investors include Bill & Melinda Gates Foundation, Bossa Invest, Ulu Ventures, AAF Management Ltd., MBX Capital.
Attivare Therapeutics is headquartered in Natick, United States.
Attivare Therapeutics is a biotechnology company that develops small-molecule therapies that modulate immune and inflammatory pathways.
Attivare Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Attivare Therapeutics — Funding & Investors." VCBacked, December 15, 2025, https://www.vcbacked.co/company/attivare-therapeutics. Accessed August 15, 2026.
VCBacked. (2025). Attivare Therapeutics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/attivare-therapeutics
{{cite web |title=Attivare Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/attivare-therapeutics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated